drugset / Trial / NCT04305678
Mepolizumab for Eosinophilic Fasciitis
NaSingle-groupOpen-labelTreatment
Summary
This is a proof of concept pilot study to investigate the efficacy of mepolizumab in the treatment of eosinophilic fasciitis.
Timeline
- Start
- 2023-02
- Primary completion
- 2023-02-15
- Completion
- 2023-02-15
Outcome
Outcome not reported
Stopped (Business): “Funding lost from Sponsor.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mepolizumab | Monoclonal antibody | 400 mg | Other |